#drug-development
Asia Drug Development Beyond China Strategic Intelligence Report 2026: Pharma R&D and Deal Trends in South Korea, Japan, and India
Asia's drug development market opportunities include China's leadership, the dominance of small molecules and oncology, and increased clinical trial activity in South Korea and India. Japan focuses on multinational trials, with licensing preferred over M&A. O…
Bioanalytical Testing Services Market Trends and Forecasts Report 2026-2035 Featuring BioAgilytix, Catalent, Charles River, Clean Cells, Coriolis, Eurofins, Genezen, SGS, Solvias, Texcell, Wuxi AppTec
The bioanalytical testing market offers growth opportunities driven by rising demand for personalized medicine, advancements in analytical technologies, and increased outsourcing to CROs to reduce costs and address complex drug development. North America lead…
Piramal Pharma Solutions Announces Partnership with Botanix to Support Drug Substance Development
Piramal Pharma Solutions has entered into an agreement with Botanix SB Inc., a subsidiary of Botanix Pharmaceuticals Limited, to support the development and commercial supply of Sofdra®. Sofdra is the first and only FDA-approved new chemical entity (NCE) for …
Cancer Vaccine Market Research Report 2026 with Analyst Recommendations - Leveraging AI and Bioinformatics for Precision Development & Fast-Track and Orphan Drug Designations - Global Forecast to 2031
Key opportunities in the cancer vaccine market include growth in preventative and therapeutic vaccines, driven by innovations in immuno-oncology and personalized medicine. The Americas lead due to advanced infrastructure, while Asia Pacific shows rapid growth…
Biosimulation Market to Grow at 16%+ CAGR Reaching USD 11.3 Billion by 2031, Driven by Increasing Adoption in Drug Development and Regulatory Applications: Mordor Intelligence
The biosimulation market is driven by the rising complexity of drug development, increasing demand for cost-efficient R&D processes, and growing adoption of modeling and simulation tools. North America leads the market, while Asia-Pacific is emerging as a hig…
Global Biosimulation Market Poised for Phenomenal Expansion at a CAGR of ~17% by 2034 | DelveInsight
The biosimulation market is witnessing robust expansion, fueled by the increasing adoption of model-informed drug development (MIDD), the growing complexity of modern drug development, and the rising emphasis on personalized and precision medicine. MIDD strat…